Latest Post

March 16, 2021

Addressing the Challenges in Research for Biologics

In recent years, an increasing variety of biologic drugs have been developed including vaccines, recombinant proteins, gene and cell therapies. In China, this increased demand will be reflected in a significant growth in the size of the bio-pharmaceutical industry. As a result, the Chinese government is increasing its investment.
Lynn Yao

Lynn Yao

Manager, Scientific Affairs, China


Search the Blog